Artemis Pharmaceuticals GmBh and Taconic Farms, Inc. Acquire Chemical Genetics Technology From CGI Pharmaceuticals, Inc.

HUDSON, N.Y. & COLOGNE, Germany--(BUSINESS WIRE)--Taconic Farms, Inc. (Hudson, NY, USA) and Artemis Pharmaceuticals GmbH (Cologne, Germany) today announced that they have jointly acquired the worldwide rights to the ASKA technology from CGI Pharmaceuticals Inc. (“CGI,” Branford, CT, USA). Representing a cutting-edge approach to in vivo kinase-related drug discovery, ASKA technology is based on the replacement of a normal kinase with a selectively modified kinase or “ASKA” (Analogue Sensitive Kinase Allele) in genetically modified mice.

Back to news